MPT: Mixed Results with LifeVest for Post-MI Prevention

ACC Conference Reporter

ACC.18 | ORLANDO, FL — A wearable cardioverter defibrillator (WCD) didn't help prevent sudden cardiac deaths in the immediate post-MI period, the 2,300-patient VEST trial found, but it did provide benefit in secondary outcomes including all-cause mortality and stroke death. Read More >>>



Keywords: ACC18, ACC Annual Scientific Session


< Back to Listings